HBM Healthcare Investments (HBMN) - Net Assets

Latest as of December 2025: CHF1.86 Billion CHF ≈ $2.36 Billion USD

Based on the latest financial reports, HBM Healthcare Investments (HBMN) has net assets worth CHF1.86 Billion CHF (≈ $2.36 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF2.04 Billion ≈ $2.58 Billion USD) and total liabilities (CHF177.19 Million ≈ $224.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HBM Healthcare Investments (HBMN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF1.86 Billion
% of Total Assets 91.32%
Annual Growth Rate 3.48%
5-Year Change -23.52%
10-Year Change 61.33%
Growth Volatility 18.82

HBM Healthcare Investments - Net Assets Trend (2002–2025)

This chart illustrates how HBM Healthcare Investments's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of HBM Healthcare Investments for the complete picture of this company's asset base.

Annual Net Assets for HBM Healthcare Investments (2002–2025)

The table below shows the annual net assets of HBM Healthcare Investments from 2002 to 2025. For live valuation and market cap data, see how much is HBM Healthcare Investments worth.

Year Net Assets Change
2025-03-31 CHF1.65 Billion
≈ $2.08 Billion		 -3.43%
2024-03-31 CHF1.70 Billion
≈ $2.15 Billion		 -3.88%
2023-03-31 CHF1.77 Billion
≈ $2.24 Billion		 -10.76%
2022-03-31 CHF1.99 Billion
≈ $2.51 Billion		 -7.67%
2021-03-31 CHF2.15 Billion
≈ $2.72 Billion		 +48.50%
2020-03-31 CHF1.45 Billion
≈ $1.83 Billion		 +9.90%
2019-03-31 CHF1.32 Billion
≈ $1.67 Billion		 +13.85%
2018-03-31 CHF1.16 Billion
≈ $1.46 Billion		 +5.67%
2017-03-31 CHF1.10 Billion
≈ $1.39 Billion		 +7.43%
2016-03-31 CHF1.02 Billion
≈ $1.29 Billion		 -5.05%
2015-03-31 CHF1.07 Billion
≈ $1.36 Billion		 +16.72%
2014-03-31 CHF920.34 Million
≈ $1.16 Billion		 +53.14%
2013-03-31 CHF600.96 Million
≈ $759.78 Million		 +9.99%
2012-03-31 CHF546.39 Million
≈ $690.79 Million		 -7.27%
2011-03-31 CHF589.23 Million
≈ $744.94 Million		 -11.55%
2010-03-31 CHF666.15 Million
≈ $842.19 Million		 +7.63%
2009-03-31 CHF618.93 Million
≈ $782.49 Million		 -34.73%
2008-03-31 CHF948.33 Million
≈ $1.20 Billion		 -20.91%
2007-03-31 CHF1.20 Billion
≈ $1.52 Billion		 +14.40%
2006-03-31 CHF1.05 Billion
≈ $1.33 Billion		 +19.46%
2005-03-31 CHF877.35 Million
≈ $1.11 Billion		 +1.56%
2004-03-31 CHF863.89 Million
≈ $1.09 Billion		 +8.02%
2003-03-31 CHF799.78 Million
≈ $1.01 Billion		 +6.83%
2002-03-31 CHF748.62 Million
≈ $946.45 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to HBM Healthcare Investments's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 12214.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings CHF1.51 Billion 91.89%
Common Stock CHF32.02 Million 1.95%
Other Comprehensive Income CHF143.25 Million 8.71%
Total Equity CHF1.65 Billion 100.00%

HBM Healthcare Investments Competitors by Market Cap

The table below lists competitors of HBM Healthcare Investments ranked by their market capitalization.

Company Market Cap
Ladder Capital Corp Class A
NYSE:LADR
 $1.32 Billion
Milkyway Chemical Supply Chain Service Co Ltd
SHG:603713
 $1.32 Billion
Hunan Er Kang Pharmaceutical
SHE:300267
 $1.32 Billion
Insigma
SHG:600797
 $1.32 Billion
Ye Chiu Metal Recycling China Ltd
SHG:601388
 $1.31 Billion
Ningbo Construction Co Ltd
SHG:601789
 $1.31 Billion
Isracard Ltd
TA:ISCD
 $1.31 Billion
Weibo Corp
NASDAQ:WB
 $1.31 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in HBM Healthcare Investments's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,703,865,000 to 1,645,431,000, a change of -58,434,000 (-3.4%).
  • Net income of 18,542,000 contributed positively to equity growth.
  • Dividend payments of 51,202,000 reduced retained earnings.
  • Share repurchases of 77,293,000 reduced equity.
  • Other comprehensive income increased equity by 997,999.
  • Other factors increased equity by 50,521,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF18.54 Million +1.13%
Dividends Paid CHF51.20 Million -3.11%
Share Repurchases CHF77.29 Million -4.7%
Other Comprehensive Income CHF998.00K +0.06%
Other Changes CHF50.52 Million +3.07%
Total Change CHF- -3.43%

Book Value vs Market Value Analysis

This analysis compares HBM Healthcare Investments's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.97x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.38x to 0.97x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-03-31 CHF170.72 CHF235.00 x
2003-03-31 CHF99.01 CHF235.00 x
2004-03-31 CHF83.21 CHF235.00 x
2005-03-31 CHF82.57 CHF235.00 x
2006-03-31 CHF93.06 CHF235.00 x
2007-03-31 CHF106.45 CHF235.00 x
2008-03-31 CHF84.88 CHF235.00 x
2009-03-31 CHF57.33 CHF235.00 x
2010-03-31 CHF64.42 CHF235.00 x
2011-03-31 CHF59.86 CHF235.00 x
2012-03-31 CHF57.94 CHF235.00 x
2013-03-31 CHF67.42 CHF235.00 x
2014-03-31 CHF106.68 CHF235.00 x
2015-03-31 CHF135.46 CHF235.00 x
2016-03-31 CHF133.27 CHF235.00 x
2017-03-31 CHF151.94 CHF235.00 x
2018-03-31 CHF165.39 CHF235.00 x
2019-03-31 CHF189.49 CHF235.00 x
2020-03-31 CHF208.25 CHF235.00 x
2021-03-31 CHF309.25 CHF235.00 x
2022-03-31 CHF285.54 CHF235.00 x
2023-03-31 CHF254.81 CHF235.00 x
2024-03-31 CHF245.80 CHF235.00 x
2025-03-31 CHF241.80 CHF235.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently HBM Healthcare Investments utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.13%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 82.88%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 1.06x
  • Recent ROE (1.13%) is below the historical average (3.77%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 -1.64% -49.39% 0.03x 1.00x CHF-87.14 Million
2003 -19.52% -357.42% 0.05x 1.01x CHF-236.12 Million
2004 7.42% 37.54% 0.20x 1.01x CHF-22.28 Million
2005 6.56% 55.66% 0.12x 1.01x CHF-30.20 Million
2006 13.82% 106.16% 0.13x 1.01x CHF40.02 Million
2007 12.59% 76.99% 0.14x 1.17x CHF31.00 Million
2008 -23.44% -104.12% 0.19x 1.20x CHF-317.14 Million
2009 -50.55% -283.80% 0.14x 1.31x CHF-374.77 Million
2010 9.91% 73.33% 0.11x 1.18x CHF-581.80K
2011 -9.57% 0.00% -0.06x 1.07x CHF-115.30 Million
2012 -4.06% 0.00% -0.03x 1.00x CHF-76.81 Million
2013 11.15% 85.80% 0.13x 1.00x CHF6.91 Million
2014 38.41% 99.09% 0.39x 1.01x CHF261.49 Million
2015 23.97% 98.70% 0.22x 1.11x CHF150.09 Million
2016 2.33% 87.43% 0.02x 1.10x CHF-78.19 Million
2017 12.48% 96.04% 0.12x 1.09x CHF27.20 Million
2018 10.01% 95.69% 0.10x 1.09x CHF84.40K
2019 13.86% 85.75% 0.15x 1.08x CHF50.87 Million
2020 12.61% 98.13% 0.12x 1.07x CHF37.82 Million
2021 35.15% 98.69% 0.34x 1.05x CHF541.12 Million
2022 -3.93% 0.00% -0.04x 1.08x CHF-276.68 Million
2023 -8.25% 0.00% -0.07x 1.09x CHF-323.59 Million
2024 -0.06% -35.21% 0.00x 1.06x CHF-171.47 Million
2025 1.13% 82.88% 0.01x 1.06x CHF-146.00 Million

Industry Comparison

This section compares HBM Healthcare Investments's net assets metrics with peer companies in the Asset Management industry.

Industry Context

  • Industry: Asset Management
  • Average net assets among peers: $1,068,169,534
  • Average return on equity (ROE) among peers: 4.84%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
HBM Healthcare Investments (HBMN) CHF1.86 Billion -1.64% 0.10x $1.32 Billion
Alpine Select AG (ALPN) $150.88 Million -69.57% 0.00x $76.22 Million
Julius Baer Gruppe AG (BAER) $5.35 Billion 11.57% 16.97x $12.36 Billion
Bellevue Group AG (BBN) $122.47 Million 12.43% 0.27x $127.19 Million
GAM Holding AG (GAM) $1.88 Billion 6.54% 0.30x $109.70 Million
Leonteq AG (LEON) $376.41 Million 16.62% 17.32x $273.70 Million
Nebag ag (NBEN) $92.92 Million 6.97% 0.01x $55.67 Million
Private Equity Holding AG (PEHN) $200.74 Million 3.68% 0.00x $149.33 Million
Partners Group Holding AG (PGHN) $356.91 Million 47.76% 0.46x $24.50 Billion
Vontobel Holding (VONN) $1.08 Billion 7.51% 5.06x $3.80 Billion

About HBM Healthcare Investments

SW:HBMN Switzerland Asset Management
Market Cap
$1.96 Billion
CHF1.55 Billion CHF
Market Cap Rank
#7930 Global
#106 in Switzerland
Share Price
CHF235.00
Change (1 day)
+1.29%
52-Week Range
CHF159.60 - CHF244.50
All Time High
CHF323.96
Categories
Companies in Switzerland Asset Management Banking & Financial
About

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds… Read more